Osaic Holdings
VTGN icon

Osaic Holdings’s VistaGen Therapeutics VTGN Stock Holding History

Osaic Holdings’s Portfolio VTGN Stock Details VTGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.1K Buy
43,888
+39,755
+962% +$24K ﹤0.01% 6604
2026
Q1 		$2.36K Sell
4,133
-1,136
-22% -$690 ﹤0.01% 6993
2025
Q4 		$3.48K Buy
5,269
+1,176
+29% +$4.25K ﹤0.01% 6880
2025
Q3 		$14.5K Sell
4,093
-400
-9% -$1.2K ﹤0.01% 6136
2025
Q2 		$8.99K Sell
4,493
-1,001
-18% -$2.27K ﹤0.01% 6222
2025
Q1 		$13.7K Sell
5,494
-5,936
-52% -$16.8K ﹤0.01% 5610
2024
Q4 		$33.7K Buy
11,430
+1,204
+12% +$3.39K ﹤0.01% 4988
2024
Q3 		$30.8K Sell
10,226
-800
-7% -$2.73K ﹤0.01% 5094
2024
Q2 		$38.4K Sell
11,026
-634
-5% -$2.75K ﹤0.01% 4882
2024
Q1 		$61.6K Buy
11,660
+1,194
+11% +$5.74K ﹤0.01% 4591
2023
Q4 		$53.8K Buy
10,466
+5,653
+117% +$21.4K ﹤0.01% 4859
2023
Q3 		$25.2K Buy
4,813
+3,668
+320% +$16.3K ﹤0.01% 5420
2023
Q2 		$2.14K Sell
1,145
-3
-0.3% -$11 ﹤0.01% 6643
2023
Q1 		$4.29K Hold
1,148
– – ﹤0.01% 6402
2022
Q4 		$4K Hold
1,148
– – ﹤0.01% 6433
2022
Q3 		$6K Sell
1,148
-209
-15% -$2.07K ﹤0.01% 6309
2022
Q2 		$36K Buy
1,357
+263
+24% +$9.29K ﹤0.01% 5201
2022
Q1 		$41K Sell
1,094
-329
-23% -$14.3K ﹤0.01% 5240
2021
Q4 		$83K Buy
1,423
+442
+45% +$28.8K ﹤0.01% 4723
2021
Q3 		$81K Buy
981
+515
+111% +$44.8K ﹤0.01% 4716
2021
Q2 		$44K Sell
466
-5,248
-92% -$389K ﹤0.01% 5141
2021
Q1 		$365K Hold
5,714
– – ﹤0.01% 3201
2020
Q4 		$333K Hold
5,714
– – ﹤0.01% 3025
2020
Q3 		$119K Hold
5,714
– – ﹤0.01% 3683
2020
Q2 		$90K Hold
5,714
– – ﹤0.01% 3761
2020
Q1 		$75K Buy
+5,714
New +$105K ﹤0.01% 3693

Other funds holding VTGN

CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
LM
Luminus Management Houston, Texas $146M AUM 27.83% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Osaic Holdings's VTGN Position: Q2 2026 in Review

Osaic Holdings increased its VistaGen Therapeutics (VTGN) stake by 962% in Q2 2026, buying an estimated $24K and bringing the position to 43,888 shares worth $10.1K. The position accounts for ﹤0.01% of the portfolio, ranked #6604.

Osaic Holdings first reported a position in VTGN in Q1 2020 and has held it in 26 quarters since. The position peaked at $365K in Q1 2021. 48 funds tracked by Wall St. Rank hold VTGN as of Q2 2026.

  • Osaic Holdings held 43,888 shares of VistaGen Therapeutics worth $10.1K as of Q2 2026.
  • Osaic Holdings bought 39,755 VistaGen Therapeutics shares in Q2 2026, an estimated $24K.
  • VistaGen Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #6604 holding.
  • Osaic Holdings first reported a position in VistaGen Therapeutics in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's VistaGen Therapeutics position peaked at $365K in Q1 2021.
  • 48 funds tracked by Wall St. Rank held VistaGen Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.